Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Fidaxomicine en vancomycine verlagen 'C. difficile'-uitscheiding en contaminatie van de omgeving
aug 2022 | Bacteriële infecties